Original research paper

Chronic Low-Dose Nonylphenol or Di-(2-ethylhexyl) Phthalate has a Different Estrogen-like Response in Mouse Uterus

Juhye Kim1, Sunyeong Cha1, Min Young Lee1, Yeon Jeong Hwang1, Eunhyeok Yang1, Chongsuk Ryou2, Hyo-Il Jung3, Yong-Pil Cheon1,
Author Information & Copyright
1Division of Developmental Biology and Physiology, School of Bioscience and Chemistry, Institute for Basic Sciences, Sungshin University, Seoul 02844, Korea
2Dept. of Pharmacy, College of Pharmacy, Hanyang University, Ansan 15588, Korea
3School of Mechanical Engineering, Yonsei University, Seoul 03722, Korea
Corresponding Author : Yong-Pil Cheon, Ph.D., Division of Developmental Biology and Physiology, School of Bioscience and Chemistry, Institute for Basic Sciences, Sungshin University, Seoul 02844, Korea. Tel: +82-2-920-7639, Fax: +82-2-920-2736, E-mail: ypcheon@sungshin.ac.kr

© Copyright 2018 The Korean Society of Developmental Biology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Nov 07, 2018 ; Revised: Nov 25, 2018 ; Accepted: Dec 08, 2018

Published Online: Dec 31, 2018


Through the development of organic synthetic skill, chemicals that mimic signaling mediators such as steroid hormones have been exposed to the environment. Recently, it has become apparent that this circumstance should be further studied in the field of physiology. Estrogenic action of chronic low-dose nonylphenol (NP) and di-(2-ethylhexyl) phthalate (DEHP) in mouse uterus was assessed in this study. Ten to twelve-week-old female mice (CD-1) were fed drinking water containing NP (50 or 500 μg/L) or DEHP (133 or 1,330 μg/L) for 10 weeks. Uterine diameter, the thickness of myometrium and endometrium, and the height of luminal epithelial cells were measured and the number of glands were counted. The expression levels of the known 17β-estradiol (E2)-regulated genes were evaluated with real-time RT-PCR methodology. The ration of uterine weight to body weight increased in 133 μg/L DEHP. Endometrial and myometrial thickness increased in 133 and 1,330 μg/L DEHP treated groups, and in 50, 500 μg/L NP and 133 μg/L DEHP, respectively. The height of luminal epithelial cell decreased in NP groups. The numbers of luminal epithelial gland were decreased in NP groups but increased in 50 μg/L DEHP group. The histological characters of glands were not different between groups. The mRNA expression profiles of the known 17β-estradiol (E2) downstream genes, Esr1, Esr2, Pgr, Lox, and Muc1, were also different between NP and DEHP groups. The expression levels dramatically increased in some genes by the NP or DEHP. Based on these results, it is suggested that the chronic low-dose NP or DEHP works as estrogen-like messengers in uterus with their own specific gene expression-regulation patterns.

Keywords: Nonylphenol; Di-(2-ethylhexyl) phthalate; Estrogen-like action; Uterus


It has been suggested that endocrine disrupting chemicals (EDCs) mimic the steroid hormone and/or inhibit the action of steroid hormones or endocrine system through classical and nonclassical pathways of steroid hormone as well as receptor-independent mechanisms (Keith, 1997; Krimsky, 2000; Bandiera, 2006; USEPA, 2017). Most of the EDCs are derived from synthetic organic chemicals and the other are from nature such as plants. The EDCs have continuously increased through the development of organic chemical synthetic skills and has threated human health and wild life (Blair et al., 2000; Browne et al., 2018). It has been revealed that ECDs can effect developmental malformations, interfere reproduction, increase cancer risks, and disturb the function of the immune and nervous system (USEPA, 2017).

Recently we reported that chronic low-dose di-(2-ethylhexyl) phthatlate (DEHP) and nonylphenol (NP) has nonmonotonic estrogenic effects in mouse reproduction (Cha et al., 2017, 2018). The last few decades, most of the studies on EDCs have been based on the pharmacological dogma, that EDCs dose are poisonous (Vandenberg et al., 2012) and toxic (Vandenberg et al., 2012; Mersha et al., 2018; van der Weijden et al., 2018). Nowadays, EDCs are challenged in the view of physiological responses and reproductive tract disorders concerned with dose exposure and periods (Huang & Li, 2014; Mersha et al., 2018; van der Weijden et al., 2018). For example, low-dose expose studies have been done in behavior, Sobolewski et al. 2014; Rebuli et al., 2015), obesity (Brulport et al., 2017), metabolism (Casals-Casas & Desvergne, 2011), and others (Casals-Casas & Desvergne, 2011; Zama & Uzumcu, 2013).

NP is derived from nonylphenol ethoxylates (NPEs), which are the metabolites of alkylphenol ethoxylates. NPEs are widely used in detergents, emulsifiers, pesticides, paints and plastics, and are also found in sewage (Purdom et al., 1994; Soares et al., 2008). Soto et al. (1991) and Shelby et al. (1996) showed that a high-dose NP had uterotrophic effects on rodents, and induced transcription in ER-transfected HeLa cells and MCF7 cells. Administration with 40 mg/kg/day NP for 14 days on guinea pigs exhibits a prevention of decrease in uterine weight following castration. The estrogenic effects on histological features of these animals like those occurring in normal cycling animals (Danzo et al., 2002). In ovariectomized rats, NP at a dose of 100 and 200 mg/kg for 3 days increased uterine weights, thickened of luminal epithelum, endometrium, and myometrium; and induced proliferation in endometrium (Zhang et al., 2007). Additionally, a low-dos NP also showed estrogenic effect in female mice (Cha et al., 2017; Di et al., 2018).

DEHP, which is also known as an estrogenic EDC is widely used as plasticizers in manufacturing polyvinyl chloride, and as it is not covalently bound to plastic, it is readily emitted to the environment (Lorz et al., 2007; Halden, 2010). DEHP is found in food wraps, medical devices, and cosmetic products. In rodents, DEHP is metabolized to mono 2-ethyl hexyl phthalate (MEHP) and 2-ethylhexanol in digestive tracts, and one of its metabolite, MEHP is observed to have more toxic effects (Grande et al., 2006; Somasundaram et al., 2016). It has been verified that DEHP has reproductive toxicity in humans and animals (Lovekamp-Swan & Davis, 2003; Lorz et al., 2007). In vivo exposure to 2 g/kg DEHP on mature Sprague-Dawley rats decreased ovarian estradiol production, prolonged estrous cycles, and stopped ovulation (Davis et al., 1994). Oral exposure to 1, 10, and 100 mg/kg body weight (BW)/day of DEHP on Wistar rats for 30 days did not change BW and wet uterine weight; but increased ovarian hormones and their receptors expression; and decreased uterine diameter and numbers of uterine glands (Somasundaram et al., 2016). In addition, it has also been recently revealed that low-dose DEHP has estrogenic effects in female (Cha et al., 2018; Julien et al., 2018).

Although the possible estrogenic effects of low-dose NP and DEHP have been suggested, the uterine responsibility to chronic low-dose NP and DEHP is not clearly evaluated. The present study performed to comparatively investigate whether chronic low-dose have estrogen-like activity on mouse uterus between NP and DEHP.


1. Animals and administration

All experimental animals were conducted in accordance with the Guide for the Care and Use of Laboratory Animals published by the National Institute of Health. CD-1 mice were maintained under standard condition at Sungshin University. Circadian rhythm kept under the 14L:10D schedule with light-on at 06:00 and clean room system. Animals were fed food and drink mentioned in Cha et al. (2017). Briefly, estrogen-free rodent diet (2018 Teklad global 18% protein rodent diets; ENVIGO, Madison, WI, USA) and water were provided ad libitum in glass bottles with stainless steel sipper tubes from weaning 21 days after birth.

Administration of NP and DEHP followed OECD Guidelines for the Testing of Chemicals–Test No. 443. 10–12-week-old animals were given NP at a dose of 50 or 500 μg/L or DEHP at a dose of 133 or 1,330 μg/L dissolved in drinking water for 10 weeks, considering that a mouse drinks approximately 4–7 mL/day water. Control group was given water without test substances. Estrous cycle was checked by smearing daily for first 2 weeks, then each normal cycling CD-1 female was chosen and bred with a male for 2 weeks (n=10 / each group). Copulatory plug was checked daily, and after 6 weeks euthanized by cervical dislocation.

To get ovariectomized mice, 2–3-month-old female mice were anesthetized with pentobarbital sodium (78 mg/kg BW) and removed ovaries. After a week, injected subcutaneously (sc.) with 0.1 mL vehicle (control) or 2 μg/kg E2 (Cat #: E8875, Sigma) in cottonseed oil for 3 days at 09:00 and sacrificed on the next day.

2. Uterus sampling and Histology

Uteri were dissected and the uterine wet weights were measured with analytical electron balancer. A part of uterus was stored at −80° until use for molecular experiments and the others were fixed overnight in Bouin's fixative. Fixed uteri were dehydrated with ethyl alcohol using Leica TP 1020, and embedded in paraffin. The paraffin block was cross-sectioned at 4 μm (Leica RM2245 microtome) and stained with hematoxylin and eosin Y. Tissues are microphotographed using Olympus B×60 microscope and Olympus DP71 microscope digital camera. Uterine diameter was measured perpendicularly to mesometrium-antimesometrium axis on 40× microphotograph with ImageJ program. Myometrium and endometrium thickness were respectively measured from longitudinal to circular smooth muscle layers and from luminal surface to beginning of circular smooth muscle layer on 100× microphotograph with ImageJ software. Epithelial cell height was measured on 400× magnification microscope with Tcapture software. Furthermore, number of endometrial glands was counted and its morphology was analyzed. To get confidence of the data, at least 4 sections per mouse were analyzed and in all directions.

3. Total RNA extraction and real-time RT-PCR

Total RNA was extracted using TRI reagent (Cat #: TR 118, Molecular Research Center, Cincinnati, OH, USA) according to manufacturer's instruction with modification. Briefly, the sample was homogenized with TRI reagent (1 mL/100 mg) and kept for 10 min at room temperature (RT). The chloroform (200 μL/mL) was added and shaken vigorously for 15 sec. Then the mixture was stored for 15 min at RT and centrifuged at 12,000 g for 15 min at 4°. The RNA was precipitated by mixing isopropanol (0.5 mL/mL), inverting several times, maintaining at RT for 10 min, and centrifuging at 12,000 g for 8 min at 4°. Purity and concentration of total RNA were assessed by NanoDrop 2000 Spectrophotometer (Cat #: ND-2000, Thermo Scientific, Wilmington, DE, USA). The total RNA was stored at −80° until used.

First strand cDNA was synthesized using AccuScript High Fidelity Reverse Transcriptase (Cat #: 600089, Agilent Technologies, CA, USA) according to the manufacturer's instruction. Shortly, reaction reagents were total RNA, AccuScript 10× RT buffer 5.0 μL, 0.5 μg/μL oligo dT primer 1.0 μL, 0.1 μg/μL random primers 1.0 μL, 100mM dNTP mix 2μL, and RNase-free DEPC-treated water. Reaction mixture was incubated at 65° for 5 min, and cooled slowly at RT to allow the primers to anneal to RNA for 10 min. Next, 100 mM DTT 4.0 μL, 40 U/μL RNase block ribonuclease inhibitor 2.0 μL (Cat #: 300152-51, Agilent Technologies, CA, USA), and AccuScript High Fidelity RT 1.0 μL were added. The mixture was incubated for at 42° for 1 hr and at 70° for 10 min to terminate cDNA synthesis. cDNA was stored at −20°.

Real-time PCR was performed using SYBR® Premix Ex TaqTM (Cat #: RR420A, TaKaRa, Japan) and Thermal Cycler Dice Real Time System TP800 (TaKaRa, Japan). Each reaction was run in triplicate. Dissociation curves were run on all reactions to ensure amplification of a single product with the appropriate melting temperature. The fold change in gene expression was calculated using the ΔΔCt method with housekeeping gene, 36B4, as an internal control.

4. Statistical analysis

Results are presented as mean±SEM. Two-way ANOVA was used to evaluate statistical difference, followed by t-test was performed for comparisons of two means. Statistical significance was considered at p<0.05.


1. The ratio of uterine wet weight to body weight increased by DEHP

The wet weight was 0.206±0.019 g in control, 0.177± 0.018 g in 50 μg/L NP, 0.208±0.001 g in 500 μg/L NP, 0.289± 0.157 g in 133 μg/L DEHP, and 0.175±0.003 g in 1,330 μg/L DEHP. The ration of uterus wet weight to BW (0.0078±0.00119) was significantly high in 133 μg/L DEHP 133 treated mice (Fig. 1). The rations were 0.00548± 0.00047 in control, 0.00478±0.00054 in 50 μg/L NP, 0.00569± 0.00077 in 500 μg/L NP, and 0.00474±0.00030 in 1,330 μg/L (Fig. 1).

Fig. 1. Uterine wet weight (g)/body weight (g) in response to NP and DEHP treatment. 10–12-week-old female mice were exposed to NP (50 or 500 μg/L) or DEHP (133 or 1,330 μg/L) in drinking water for 10 weeks. DEHP 133 μg/L increased uterine wet weight/ body weight. Data are presented as means±SEM. ap<0.05, two way ANOVA; * p<0.05, significantly difference compared control vs. experimental group. Ctrl, control; NP, nonylphenol; DEHP, di-(2-ethylhexyl) phthalate.
Download Original Figure

There were no statistical significance between control and EDCs treated groups in uterine diameter. However, the diameter tended to increase in 133 μg/L DEHP. Compared with the NP treated groups, the diameter in 133 μg/L DEHP significantly increased (Fig. 2).

Fig. 2. Uterine diameter (μm) in response to NP and DEHP treatment. 10–12-week-old female mice were exposed to NP (50 or 500 μg/L) or DEHP (133 or 1,330 μg/L) in drinking water for 10 weeks. No significant change was presented comparing with control. Data are presented as means±SEM. ap<0.05, two way ANOVA; #p<0.05, significantly difference compared NP groups vs. DEHP groups. Ctrl, control; NP, nonylphenol; DEHP, di-(2-ethylhexyl) phthalate.
Download Original Figure
2. Histological characteristics were affected by NP and DEHP

Myometrium thickness significantly increased by 50 μg/L NP, 500 μg/L NP, and 133 μg/L DEHP groups (Fig. 3). On the other hand, the thickness of endometrium was increased only by DEHP treated groups (Fig. 3).

Fig. 3. Photomicrography of endometrium and myometrium and their thickness (μm) in response to NP and DEHP treatment. 10–12-week-old female mice were exposed to NP (50 or 500 μg/L) or DEHP (133 or 1,330 μg/L) in drinking water for 10 weeks. (A–E) Representative H&E stained uterus (×100). (A) Control. E, endometrium; M, myometrium, (B) NP 50 μg/L, (C) NP 500 μg/L, (D) DEHP 133 μg/L, (E) DEHP 1,330 μg/L, (F) Endometrium thickness (μm), DEHP 133 and 1,330 μg/L increased endometrium thickness, (G) Myometrium thickness (μm) including longitudinal and circular muscle layers. NP 50 and 500 μg/L and DEHP 133 μg/L increased myometrium thickness. Data are presented as means±SEM. ap<0.05, two way ANOVA; * p<0.05, significantly difference compared control vs. experimental group. Ctrl, control; NP, nonylphenol; DEHP, di-(2-ethylhexyl) phthalate.
Download Original Figure

In the height of luminal epithelial cells, the effects of NP and DEHP were also different by EDCs. The height was significantly shorter in NP treated groups than the control. However, there was no difference of the epithelial height in DEHP treated groups compared with the control (Fig. 4). The number of endometrial glands were less in NP treated groups than the control and DEHP treated groups. In 133 μg/L DEHP treated group, the number of glands significantly increased (Fig. 5F). There were no difference in morphology of the glands between treatment groups. All of the groups including the control had normal, daughter, conglomerated, and few cystic glands (Fig. 5A–E).

Fig. 4. Photomicrograpy of luminal epithelial cell and the height (μm) in response to NP and DEHP treatment. 10–12-week-old female mice were exposed to NP (50 or 500 μg/L) or DEHP (133 or 1,330 μg/L) in drinking water for 10 weeks. (A–E) Representative H&E stained uterus (×600). (A) Control, (B) NP 50 μg/L, (C) NP 500 μg/L, (D) DEHP 133 μg/L, (E) DEHP 1,330 μg/L, (F) Epithelial cell height (μm). NP 50 and 500 μg/L decreased epithelial cell height. Data are presented as means±SEM. ap<0.05, two way ANOVA; * p<0.05 significantly difference compared control vs. experimental group. Ctrl, control; NP, nonylphenol; DEHP, di-(2-ethylhexyl) phthalate.
Download Original Figure
Fig. 5. Number of luminal endometrial glands and photomicrography of endometrial glands in response to NP and DEHP treatment. 10–12-week-old female mice were exposed to NP (50 or 500 μg/L) or DEHP (133 or 1,330 μg/L) in drinking water for 10 weeks. The bar is 500 μm. The inset is the magnified image of the dotted box area. A, vehicle; B, E2; C, 50 μg/L NP; D, 500 μg/L NP; E, 133 μg/L DEHP; F, 1,330 μg/L DEHP. The numbers of luminal endometrial gland were significantly less in NP groups compared with control but significantly increased in 133 μg/L DEHP group. Data are presented as means±SEM. ap<0.05, two way ANOVA; * p<0.05, significantly difference compared control vs. experimental group; #p<0.05, significantly difference compared NP groups vs. DEHP groups. Ctrl, control; NP, nonylphenol; DEHP, di-(2-ethylhexyl) phthalate.
Download Original Figure
3. Expression of estrogen-regulated genes were different by the EDCs and their dose

Esr1, Esr2, Prg, Lox, Egr1 and Muc1 are well known E2 downstream genes. As expected the expression levels of Esr1, Pgr, Lox and Muc1 mRNAs increase by administration E2 for 3 days as mentioned in materials and methods. Yet, Esr2 and Egr1 mRNAs did not increased (Fig. 6). Expression levels of Esr1 and Lox mRNAs were significantly higher in 500 μg/L NP, but were significantly lower in DEHP treated groups than the control (vehicle) and E2 treated group (Fig. 6A,D). In the case of Esr2, its expression levels were significantly higher in 50 μg/L NP, but were significantly lower in DEHP treated groups than the vehicle and E2 treated group (Fig. 6B). Pgr mRNA expression significantly decreased in 500 μg/L NP treatment compared with the control. The expressed mRNA levels were significantly lower in NP and DEHP treated groups than the E2 treated group (Fig. 6C). The expression levels of Muc1 mRNA significantly decreased in NP treated groups, but significantly increased in DEHP treated groups compared to the vehicle. Muc1 expression was significantly lower in NP treated groups than the E2 treated group. However, its expression was significantly higher in 133 μg/L DEHP treated group than the E2 treated group (Fig. 6E). In the case of Egr1 gene, its expression levels were not different between groups (Fig. 6F) as expected.

Fig. 6. Expression profiles of estrogen-regulated mRNA level in ovariectomized mouse uterus. 2–3-month-old ovariectomized mice were injected subcutaneously with 0.1 mL vehicle or 2 μg/kg E2 in cottonseed oil for 3 days. NP or DEHP were administered according to the OECD Guidelines for the Testing of Chemicals–Test No. 443. (A) Esr1 mRNA, (B) Esr2 mRNA, (C) Pgr mRNA, (D) Lox mRNA, (E) Muc1 mRNA, (F) Egr1 mRNA. Uterine gene expression to the E2, NP, and DEHP were different between them. * p<0.05, significantly difference compared control vs. experimental group; #p<0.05, significantly difference compared E2 group vs. EDCs groups. Ctrl, control; NP, nonylphenol; DEHP, di-(2-ethylhexyl) phthalate; EDCs, endocrine disrupting chemicals.
Download Original Figure


E2 (40 ng/day in mice) is known to have uterine hypertrophic effects, as it increases uterine weight, diameter, endometrium thickness and myometrium thickness, which corresponds to proliferation on endometrial, myometrial and epithelial cells as well as hypertrophy of uterine epithelial cells (Papaconstantinou et al., 2000). Previously we reported the estrogenic effects of chronic low-dose NP and DEHP in the reproduction of mouse (Cha et al., 2017; Cha et al., 2018). Interestingly chronic low-dose NP and DEHP showed the estrogenic uterine response as seen in the results.

Chronical exposure with low-dose NP, did not induce uterine weight gain nor did it increase the diameter. The endometrial thickness did not increase, but the myometrial thickness increased by 50 and 500 μg/L NP treatment. The height of luminal epithelial cells and the number of luminal epithelial glands were smaller than the control both in 50 and 500 μg/L NP. This shows that the chronic low-dose NP did not induce uterine weight gain, but stimulated the epithelial cells. Previously, it has been suggested that ERα-specific agonist induces uterine weight increase but ERβ-specific agonist does not (Frasor et al., 2003). ERα is mainly expressed in the uterine epithelium, and causes proliferation of epithelial cells based on the inter-regulation with stromal ERs (Somasundaram et al., 2016). ERβ modulates the effects of ERα and suppresses the endometrial proliferation and uterotrophic effects (Weihua et al., 2000; Somasundaram et al., 2016). Therefore, it may be suggested that this examined dose of NP in the present research did not stimulate ERα in stroma cells and others, but stimulate ERβ. In contrast, the previous suggestion of NP's role (100 or 200 mg/kg BW) in uterus as hyperplasia factor (Zhang et al., 2007) is denied in the case of chronic low-dose treatment.

In the case of DEHP, 133 μg/L DEHP induced the gain of uterine weight, and increased the diameter of uterus. Endometrial thickness increased by the both 133 and 1,330 μg/L DEHP. Myometrial thickness increased by 133 μg/L DEHP. Additionally, the number of glands increased by 133 μg/L DEHP. These results indicate that DEHP has nonmonotonic effects in uterus. Recently, it has been reported that DEHP induced leiomyoma cells to have higher viability and lower apoptosis rate (Kim, 2018). In vitro treatment with DEHP has suggested increased viability of endometrial stromal cells, a precondition to endometriosis (Scsukova et al., 2016). 30 days exposure of 200 μg/kg/day DEHP on uterus of adult female CD-1 mice reduced epithelial cell proliferation and increased the number of uterine glands. Proliferation of endometrial stromal cells increased at 200 μg/kg/day, 20 mg/kg/day and 200 mg/kg/day DEHP (Richardson et al., 2018). Besides, it is known that DEHP bind to ERα but not ERβ (Satoh et al., 2001; Takeuchi et al., 2005). Combining with the results of Frasor and Colleagues (2003), low-dose DEHP (133 μg/L) can work with ERα in uterus.

In all groups, cystic, daughter and conglomerated glands were observed. It has been reported that 25-day-old prepubertal mice that were injected 0.1 mL oil as vehicle for 20 consecutive days did not exhibit daughter and conglomerated glands (Elia et al., 2008). Another study demonstrated that all those types of glands were observed in ovariectomized mice that were injected with 20 μg/kg BW/week E2 for 30–90 (Gunin et al., 2001). The mice used in the current study were not ovariectomized. Hence, this may reflect the estrogenic action on endometrial glands of the control group as well as the experimental groups. Collectively, these histological features indicate weak potential estrogenic effects of chronic small dose exposure to the chemicals on mouse uterus.

Pgr is expressed through estradiol-induced ERα action (Somasundaram et al., 2016). The p-nonylphenol extracted from modified polystyrene induce cell proliferation with up-regulation of Pgr expression in MCF7 cells (Soto et al., 1991). At dose of 1, 10, and 100 mg/kg BW/day DEHP for 30 days, Pgr mRNA expression decreased (Somasundaram et al., 2016). However, interestingly, our results were controversy to the previous study: Chronic exposure of low-dose NP or DEHP did not induce higher expression of Pgr mRNA. 500 μg/L NP suppressed the expression of Pgr mRNA. On the other hand, in the case of Esr1 and Lox genes, chronic 500 μg/L NP administration significantly induced higher expression of Esr1 and Lox mRNAs expression, but DEHPs suppressed their expression than vehicle and E2 treatment group. It is known that Esr2 gene expression is downregulated by E2. Interestingly, Esr2 mRNA expression increased by 50 μg/L NP administration, and down regulated by chronic low-dose DEHPs. Therefore, the expression of Esr1, Lox, and Esr2 were similar on agonistic regulation by chronic low-dose NP and antagonist regulation by chronic low-dose DEHP.

Egr1 is rapidly and transiently up-regulated in uterus by E2 (Guo et al., 2014). As expected in this model, Egr1 mRNA levels did not changed. In the case of Muc1 gene, its expression is suppressed by chronic low-dose NP administration, but induced by chronic low-dose DEHP administration as in dose-dependent manner. Therefore, the expression of Muc1 was similar on agonistic regulation by chronic low-dose DEHP and antagonist regulation by chronic low-dose NP.

One of the characteristics of estrogen is biphasic physiological process, likes in gonadotropin secretion feedback (Herbison, 2008). The chronic low-dose NP and DEHP have dosage dependent gene expression response in uterus that may be the results of affinity to the ERs, though the effects of EDCs can be appeared by nuclear receptor, nonclassical receptor, and receptor-independent mechanisms. ERs are expressed in all cell types of uterus; ERα is mainly expressed in luminal epithelium and stroma; and ERβ is localized in myometrium and stroma (Weihua et al., 2000; Cunha et al., 2004; Wada-Hiraike et al., 2006). In addition, ERα and ERβ colocalize in the nuclei of stroma and in the epithelial cells of gland under the control of E2 and progesterone. Kuiper and his colleagues (1998) suggested that some phytoestrogen such as genistein, kaempferol. apigenin, and kaempferol have a bigger affinity to ERβ than ERα. Binding affinity of NP to the ERα and ERβ is 0.05 and 0.09, respectively (Kuiper et al., 1998). NP has bigger affinity than the others (octylphenol, heptyloxyphenol, etc) and affinity IC50 is 2.40–4.73×10–6. The IC50 of E2 is 8.99×10–10 (Blair et al., 2000). On the other hand, DEHP has very weak competition for the ER and 78% [3H]-E2 bind to ER with IC50 is >1.00×10–3. Furthermore, ERα and ERβ have opposite effects on gene transcription (Paech et al., 1997). To uncover the possible physiological role of chronic-low dose NP and DEHP, further studies in the level of genetic information usage is needed. This study clearly suggests that chronic lower-dose administration of NP and DEHP are still potential to have estrogen like roles in uterus as EDCs. It also shows that chronic low-dose NP has nonmonotonic effects in uterus.


This study was supported by a grant of National Research Foundation of Korea (NRF-2015M3A9D7067365) and Korea Health Industry Development Institute (KHIDI), Ministry of Health & Welfare, Korea (grant number: H16C1085).



Bandiera SM. 2006; Reproductive and endocrine effects of p-nonylphenol and methoxychlor: a review. Immun Endoc Metab Agents Med Chem. 6:15-26.


Blair RM, Fang H, Branham WS, Hass BS, Dial SL, Moland CL, Tong W, Shi L, Perkins R, Sheehan DM. 2000; The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol Sci. 54:138-153


Browne P, Kleinstreuer NC, Ceger P, Deisenroth C, Baker N, Markey K, Thomas RS, Judson RJ, Casey W. 2018; Development of a curated Hershberger database. Reprod Toxicol. 81:259-271


Brulport A, Le Corre L, Chagnon MC. 2017; Chronic exposure of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces an obesogenic effect in C57BL/6J mice fed a high fat diet. Toxicology. 390:43-52


Casals-Casas C, Desvergne B. 2011; Endocrine disruptors: From endocrine to metabolic disruption. Annu Rev Physiol. 73:135-162


Cha S, Baek JW, Ji HJ, Choi JH, Kim C, Le MY, Hwang YJ, Yang E, Lee SH, Jung HI, Cheon YP. 2017; Disturbing effects of chronic low-dose 4-nonylphenol exposing on gonadal weight and reproductive outcome over one-generation. Dev Reprod. 21:121-130


Cha S, Jung K, Lee MY, Hwang YJ, Yang E, Lee SH, Jung HI, Cheon YP. 2018; Nonmonotinic effects of chronic low-dose di (2-ethylhexyl) phthalate on gonadal weight and reproductive. Dev Reprod. 22:85-94


Cunha GR, Cooke PS, Kurita T. 2004; Role of stromal-epithelial interactions in hormonal response. Arch Histol Cytol. 67:417-434


Danzo BJ, Shappell HW, Banerjee A, Hachey DL. 2002; Effects of nonylphenol, 1,1-dichloro-2,2-bis (p-chlorophenyl) ethylene (p,p′-DDE), and pentachlorophenol on the adult female guinea pig reproductive tract. Reprod Toxicol. 16:29-43


Davis BJ, Maronpot RR, Heindel JJ. 1994; Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol Appl Pharmacol. 128:216-223


Di QN, Cao WX, Xu R, Lu L, Xu Q, Wang XB. 2018; Chronic low-dose exposure of nonylphenol alters energy homeostasis in the reproductive system of female rats. Toxicol Appl Pharmacol. 348:67-75


Elia E, Vighi S, Lombardi E, Motta AB. 2008; Detrimental effects of hyperandrogenism on uterine functions. Int Immunopharmacol. 8:1827-1834


Frasor J, Barnett DH, Danes JM, Hess R, Parlow AF, Katzenellenbogen BS. 2003; Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology. 144:3159-3166


Grande SW, Andrade AJM, Talsness CE, Grote K, Chahoud I. 2006; A dose-response study following in utero and lactational exposure to di (2-ethylhexyl) phthalate: Effects on female rat reproductive development. Toxicol Sci. 91:247-254


Gunin AG, Mashin IN, Zakharov DA. 2001; Proliferation, mitosis orientation and morphogenetic changes in the uterus of mice following chronic treatment with both estrogen and glucocorticoid hormones. J Endocrinol. 169:23-31


Guo B, Tian XC, Li DD, Yang ZQ, Cao H, Zhang QL, Liu JX, Yue ZP. 2014; Expression, regulation and function of Egr1 during implantation and decidualization in mice. Cell Cycle. 13:2626-2640


Halden RU. 2010; Plastics and health risks. Annu Rev Public Health. 31:179-194


Herbison AE. 2008; Estrogen positive feedback to gonadotropin-releasing hormone (GnRH) neurons in the rodent: The case for the rostral periventricular area of the third ventricle (RP3V). Brain Res Rev. 57:277-287


Huang C, Li X. 2014; Maternal cypermethrin exposure during the perinatal period impairs testicular development in C57BL male offspring. PLOS ONE. 9:e96781


Julien B, Pinteur C, Vega N, Labaronne E, Vidal H, Naville D, Le Magueresse-Battistoni B. 2018; Evidence for estrogeno-mimetic effects of a mixture of low-dose pollutants in a model of ovariectomized mice. Environ Toxicol Pharmacol. 57:34-40


Keith LH. 1997; Environmental Endocrine Disruptors: A Handbook of Property Data. John Wiley & Sons, Inc. New York: pp p. 1-1232.


Kim JH. 2018; Analysis of the in vitro effects of di‑(2‑ethyl- hexyl) phthalate exposure on human uterine leiomyoma cells. Exp Ther Med. 15:4972-4978


Krimsky S. 2000; Hormonal Chaos: The Scientific and Social Origins of the Environmental Endocrine Hypothesis. Johns Hopkins University Press. Baltimore, MD: pp p. 1-284.


Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. 1998; Iteraction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 139:4252-4263


Lorz PM, Towae FK, Enke W, Jackh R, Bhargava N, Hillesheim W. 2007 Phthalic acid and derivatives.In In: Ullmann F, editor.ed Ullmann's Encyclopedia of Industrial Chemistry. Wiley-Vch. .


Lovekamp-Swan T, Davis BJ. 2003; Mechanisms of phthalate ester toxicity in the female reproductive system. Environ Health Perspect. 111:139-145


Mersha MD, Sanchez KR, Temburni MK, Dhillon HS. 2018; Long-term behavioral and reproductive consequences of embryonic exposure to low-dose toxicants. J Vis Exp. 133:e56771.


Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS. 1997; Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1508-1510


Papaconstantinou AD, Umbreit TH, Fisher BR, Goering PL, Lappas NT, Brown KM. 2000; Bisphenol A-induced increase in uterine weight and alterations in uterine morphology in ovariectomized B6C3F1 mice: Role of the estrogen receptor. Toxicol Sci. 56:332-339


Purdom CE, Hardiman PA, Bye VVJ, Eno NC, Tyler CR, Sumpter JP. 1994; Estrogenic effects of effluents from sewage treatment works. Chem Ecol. 8:275-285.


Rebuli ME, Camacho L, Adonay ME, Relf DM, Aylor DL, Patisaul HB. 2015; Impact of low-dose oral exposure to bisphenol A (BPA) on juvenile and adult rat exploratory and anxiety behavior: A CLARITY-BPA consortium study. Toxicol Sci. 148:341-354


Richardson KA, Hannon PR, Johnson-Walker YJ, Myint MS, Flaws JA, Nowak RA. 2018; Di (2-ethylhexyl) phthalate (DEHP) alters proliferation and uterine gl and numbers in the uteri of adult exposed mice. Reprod Toxicol. 77:70-79


Satoh K, Nagai F, Aoki N. 2001; Several environmental pollutants have binding affinities for both androgen receptor and estrogen receptor α. J Health Sci. 47:495-501.


Scsukova S, Rollerova E, Bujnakova Mlynarcikova A. 2016; Impact of endocrine disrupting chemicals on onset and development of female reproductive disorders and hormone-related cancer. Reprod Biol. 16:243-254


Shelby MD, Newbold RR, Tully DB, Chae K, Davis VL. 1996; Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect. 104:1296-1300


Soares A, Guieysse B, Jefferson B, Cartmell E, Lester JN. 2008; Nonylphenol in the environment: A critical review on occurrence, fate, toxicity and treatment in wastewaters. Environ Int. 34:1033-1049


Sobolewski M, Conrad K, Allen JL, Weston H, Martin K, Lawrence BP, Cory-Slechta DA. 2014; Sex-specific enhanced and behavioral toxicity induced by maternal exposure to a mixture of low dose endocrine-disrupting chemicals. Nerurotoxicology. 45:121-130.


Somasundaram DB, Manokaran K, Selvanesan BC, Bhaskaran RS. 2016; Impact of di-(2-ethylhexyl) phthalate on the uterus of adult Wistar rats. Hum Exp Toxicol. 36:565-572


Soto AM, Justicia H, Wray JW, Sonnenschein C. 1991; p-nonyl-phenol: An estrogenic xenobiotic released from “modified” polystyrene. Environ Health Perspect. 92:167-173


Takeuchi S, Iida M, Kobayashi S, Jin K, Matsuda T, Kojima H. 2005; Differential effects of phthalate esters on transcriptional activities via human estrogen receptors alpha and beta, and androgen receptor. Toxicology. 210:223-233


USEPA. 2017 What is endocrine disruption?. https://www.epa.gov/endocrine-disruption/what-ndocrine-disruptioncited 2018 Dec; 20


Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, Zoeller RT, Myers JP. 2012; Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses. Endocr Rev. 33:378-455


van der Weijden VA, Floter VL, Ulbrich SE. 2018; Gestational oral low-dose estradiol-17β induces altered DNA methylation of CDKN2D and PSAT1 in embryos and adult offspring. Sci Rep. 8:7494 doi:10.1038/s41598-018-25831-9


Wada-Hiraike O, Hiraike H, Okinaga H, Imamov O, Barros RP, Morani A, Omoto Y, Warner M, Gustafsson JA. 2006; Role of estrogen receptor beta in uterine stroma and epithelium: Insights from estrogen receptor beta–/– mice. Proc Natl Acad Sci USA. 103:18350-18355


Weihua Z, Saji S, Makinen S, Cheng G, Jensen EV, Warner M, Gustafsson JA. 2000; Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc Natl Acad Sci USA. 97:5936-5941


Zama AM, Uzumcu M. 2013; Targeted genome-wide methylation and gene expression analyses reveal signaling pathways involved in ovarian dysfunction after developmental EDC exposure in rats. Biol Reprod. 88:52 doi:10.1095/biolreprod.112.104802


Zhang W, Yang J, Wang J, Xia P, Xu Y, Jia H, Chen Y. 2007; Comparative studies on the increase of uterine weight and related mechanisms of cadmium and p-nonylphenol. Toxicology. 24:84-91.